lorazepam has been researched along with Cardiovascular Diseases in 5 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lorazepam was administered to 38 patients with moderate to severe anxiety associated with cardiovascular symptomatology." | 2.64 | Antianxiety effects of lorazepam in patients with cardiovascular symptomatology. ( Finkel, S, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirnovin, R | 1 |
| Sanchez-Pinto, LN | 1 |
| Okuhara, C | 1 |
| Lieu, P | 1 |
| Koh, JY | 1 |
| Rodgers, JW | 1 |
| Nelson, LP | 1 |
| Richards, JR | 1 |
| Lange, RA | 1 |
| Arnold, TC | 1 |
| Horowitz, BZ | 1 |
| Pandit, UA | 1 |
| Kothary, SP | 1 |
| Samra, SK | 1 |
| Domino, EF | 1 |
| Pandit, SK | 1 |
| Finkel, S | 1 |
| Samet, CM | 1 |
| Geller, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Auricular Acupressure as an Adjunct Treatment for Opioid Tapering in a Pediatric Cardiac Intensive Care Unit: A Pilot Feasibility Study[NCT05025384] | 40 participants (Actual) | Interventional | 2021-10-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lorazepam and Cardiovascular Diseases
| Article | Year |
|---|---|
Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Cardiovascular Diseases; | 1978 |
4 other studies available for lorazepam and Cardiovascular Diseases
| Article | Year |
|---|---|
Implementation of a Risk-Stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU.
Topics: Analgesics, Opioid; Benzodiazepines; Cardiovascular Diseases; Female; Humans; Hydromorphone; Infant; | 2018 |
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiet | 2017 |
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalogra | 1983 |
Anxiety associated with cardiovascular disorders: a study using lorazepam.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Cardiovascular Diseases; Double-Blind Method; Female; Hum | 1979 |